🚀 VC round data is live in beta, check it out!
Remedent Valuation Multiples
Discover revenue and EBITDA valuation multiples for Remedent and similar public comparables like Chordate Medical Holding, EvokAI, Epigenomics, Inhalation Sciences SWE and more.
Remedent Overview
About Remedent
Remedent Inc is a manufacturer of cosmetic dentistry products in Europe. The company is engaged in the research, development, and manufacturing of oral care and cosmetic dentistry products. It designs, develops, manufactures, and distributes cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, the Middle East, and the United States.
Founded
1996
HQ
Employees
5
Website
Sectors
Financials (FY)
EV
$14K
Remedent Stock Performance
Remedent has current market cap of $14K, and enterprise value of $14K.
Market Cap Evolution
Remedent's stock price is $0.00.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $14K | $14K | 0.0% | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialRemedent Valuation Multiples
Remedent Financial Valuation Multiples
As of March 13, 2026, Remedent has market cap of $14K and EV of $14K.
Equity research analysts estimate Remedent's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $14K | XXX | $14K | XXX | XXX | XXX |
| EV (current) | $14K | XXX | $14K | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Remedent Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Remedent Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Chordate Medical Holding | XXX | XXX | XXX | XXX | XXX | XXX |
| EvokAI | XXX | XXX | XXX | XXX | XXX | XXX |
| Epigenomics | XXX | XXX | XXX | XXX | XXX | XXX |
| Inhalation Sciences SWE | XXX | XXX | XXX | XXX | XXX | XXX |
| Nuwellis | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Remedent M&A Activity
Remedent acquired XXX companies to date.
Last acquisition by Remedent was on XXXXXXXX, XXXXX. Remedent acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Remedent
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialRemedent Investment Activity
Remedent invested in XXX companies to date.
Remedent made its latest investment on XXXXXXXX, XXXXX. Remedent invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Remedent
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Remedent
| When was Remedent founded? | Remedent was founded in 1996. |
| Where is Remedent headquartered? | Remedent is headquartered in Belgium. |
| How many employees does Remedent have? | As of today, Remedent has over 5 employees. |
| Who is the CEO of Remedent? | Remedent's CEO is Guy De Vreese. |
| Is Remedent publicly listed? | Yes, Remedent is a public company listed on OTC Pink Sheets. |
| What is the stock symbol of Remedent? | Remedent trades under REMI ticker. |
| When did Remedent go public? | Remedent went public in 2000. |
| Who are competitors of Remedent? | Remedent main competitors are Chordate Medical Holding, EvokAI, Epigenomics, Inhalation Sciences SWE. |
| What is the current market cap of Remedent? | Remedent's current market cap is $14K. |
| Is Remedent profitable? | No, Remedent is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.